Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin

The Dialysis Patients Response to IV Iron with Elevated Ferritin (DRIVE) study demonstrated the efficacy of intravenous ferric gluconate to improve hemoglobin levels in anemic hemodialysis patients who were receiving adequate epoetin doses and who had ferritin levels between 500 and 1200 ng/ml and t...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Kapoian, Toros, O'Mara, Neeta B., Singh, Ajay K., Moran, John, Rizkala, Adel R., Geronemus, Robert, Kopelman, Robert C., Dahl, Naomi V., Coyne, Daniel W.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Nephrology 2008
Onderwerpen:
Clinical Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2396742/
https://ncbi.nlm.nih.gov/pubmed/18216316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2007050606
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items